Clinical Trial Update: A ReaL World Study of DS-8201

View source ↗

Summary

This update reports a real-world study of DS-8201 (trastuzumab deruxtecan) for metastatic breast cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DS-8201 (trastuzumab deruxtecan) (trastuzumab deruxtecan)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer Metastatic, Treatment Efficacy | Status: ACTIVE_NOT_RECRUITING